NEA Management Company as of June 30, 2015
Portfolio Holdings for NEA Management Company
NEA Management Company holds 34 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 27.2 | $521M | 8.9M | 58.79 | |
| Groupon | 11.6 | $222M | 44M | 5.03 | |
| Ardelyx (ARDX) | 8.6 | $164M | 10M | 15.97 | |
| Supernus Pharmaceuticals (SUPN) | 6.8 | $130M | 7.6M | 16.98 | |
| Epizyme | 6.5 | $124M | 5.1M | 24.00 | |
| Opower | 5.4 | $104M | 9.0M | 11.51 | |
| Clovis Oncology | 5.2 | $100M | 1.1M | 87.88 | |
| Glycomimetics (GLYC) | 3.6 | $68M | 8.6M | 7.95 | |
| Dermira | 3.2 | $62M | 3.5M | 17.55 | |
| Nevro (NVRO) | 2.8 | $53M | 993k | 53.75 | |
| Vitae Pharmaceuticals | 2.0 | $38M | 2.6M | 14.40 | |
| Aerohive Networks | 1.7 | $33M | 4.7M | 6.98 | |
| Loxo Oncology | 1.7 | $32M | 1.8M | 18.03 | |
| Trevena | 1.6 | $30M | 4.8M | 6.26 | |
| Tracon Pharmaceuticals | 1.1 | $21M | 1.9M | 11.33 | |
| Trivascular Technologies | 1.1 | $21M | 3.9M | 5.35 | |
| Care | 1.0 | $19M | 3.3M | 5.92 | |
| Lexicon Pharmaceuticals | 1.0 | $19M | 2.4M | 8.05 | |
| Orexigen Therapeutics | 1.0 | $18M | 3.7M | 4.95 | |
| Zosano Pharma | 0.8 | $16M | 2.2M | 7.25 | |
| Sunesis Pharmaceuticals | 0.7 | $14M | 4.7M | 3.01 | |
| Millennial Media | 0.7 | $13M | 8.2M | 1.62 | |
| Targacept | 0.7 | $13M | 4.6M | 2.79 | |
| Arca Biopharma | 0.6 | $12M | 10M | 1.15 | |
| Zhone Technologies | 0.6 | $11M | 4.8M | 2.24 | |
| Rigel Pharmaceuticals | 0.5 | $10M | 3.2M | 3.21 | |
| Roka Bioscience | 0.4 | $8.4M | 3.2M | 2.60 | |
| Exelixis (EXEL) | 0.4 | $8.3M | 2.2M | 3.76 | |
| Aurinia Pharmaceuticals (AUPH) | 0.4 | $7.7M | 2.5M | 3.02 | |
| Channeladvisor | 0.3 | $6.7M | 557k | 11.95 | |
| Cvent | 0.3 | $6.3M | 244k | 25.78 | |
| Paratek Pharmaceuticals | 0.2 | $4.5M | 174k | 25.77 | |
| ArQule | 0.2 | $4.0M | 2.5M | 1.60 | |
| Agile Therapeutics | 0.1 | $1.1M | 134k | 8.59 |
